Abstract
The ability of commercially available PCR-based assays to accurately detect or quantitate human immunodeficiency virus type 1 (HIV-1) DNA or RNA in individuals predominantly infected with HIV-1 subtypes A and D is not known. Therefore, peripheral leukocytes from 43 individuals in Kampala, Uganda, positive for HIV by the Western blot (immunoblot) assay were tested by using the Roche AMPLICOR HIV-1 assay for the detection of DNA gag sequences. Plasma from these same individuals was tested by using the Roche HIV-1 AMPLICOR MONITOR HIV-1 assay for the quantitation of HIV-1 RNA gag sequences. In addition, peripheral leukocytes were tested for HIV-1 DNA by using a lower annealing temperature or a different primer pair for the HIV-1 pol region. The proportions of individuals with detectable HIV-1 DNA and RNA gag sequences by the Roche assays were 74 and 90%, respectively. The proportions positive for HIV-1 DNA sequences by using a 50 degrees C annealing temperature or the pol primer pair were 71 and 98%, respectively. In summary, the standard Roche assay did not detect HIV-1 DNA sequences in a significant number of HIV-1-infected individuals in Uganda. However, use of a pol primer pair increased the sensitivity of the assay to 98%. The sensitivity of the Roche AMPLICOR MONITOR assay for the detection and quantitation of HIV-1 RNA sequences was significantly higher than that of the DNA-based assay, but the efficiency of the assay, and hence, the accuracy of the values obtained with RNA, is not known. Modifications to existing assays are needed to enhance the sensitivities and accuracies of these commercially available assays for use in developing countries where non-B HIV-1 subtypes predominate.
Full Text
The Full Text of this article is available as a PDF (67.0 KB).
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Bremer J. W., Lew J. F., Cooper E., Hillyer G. V., Pitt J., Handelsman E., Brambilla D., Moye J., Hoff R. Diagnosis of infection with human immunodeficiency virus type 1 by a DNA polymerase chain reaction assay among infants enrolled in the Women and Infants' Transmission Study. J Pediatr. 1996 Aug;129(2):198–207. doi: 10.1016/s0022-3476(96)70243-3. [DOI] [PubMed] [Google Scholar]
- Coombs R. W., Welles S. L., Hooper C., Reichelderfer P. S., D'Aquila R. T., Japour A. J., Johnson V. A., Kuritzkes D. R., Richman D. D., Kwok S. Association of plasma human immunodeficiency virus type 1 RNA level with risk of clinical progression in patients with advanced infection. AIDS Clinical Trials Group (ACTG) 116B/117 Study Team. ACTG Virology Committee Resistance and HIV-1 RNA Working Groups. J Infect Dis. 1996 Oct;174(4):704–712. doi: 10.1093/infdis/174.4.704. [DOI] [PubMed] [Google Scholar]
- Dickover R. E., Garratty E. M., Herman S. A., Sim M. S., Plaeger S., Boyer P. J., Keller M., Deveikis A., Stiehm E. R., Bryson Y. J. Identification of levels of maternal HIV-1 RNA associated with risk of perinatal transmission. Effect of maternal zidovudine treatment on viral load. JAMA. 1996 Feb 28;275(8):599–605. [PubMed] [Google Scholar]
- Dunn D. T., Brandt C. D., Krivine A., Cassol S. A., Roques P., Borkowsky W., De Rossi A., Denamur E., Ehrnst A., Loveday C. The sensitivity of HIV-1 DNA polymerase chain reaction in the neonatal period and the relative contributions of intra-uterine and intra-partum transmission. AIDS. 1995 Sep;9(9):F7–11. doi: 10.1097/00002030-199509000-00001. [DOI] [PubMed] [Google Scholar]
- Epstein H., Guay L., Hom D., Mmiro F., Ndugwa C., Marum L., Olness K., Piwowar E., Kataaha P., Baenziger J. Lack of association between anti-V3 loop antibodies and perinatal transmission of HIV-1 in Kampala, Uganda. Pediatr AIDS HIV Infect. 1994 Dec;5(6):350–356. [PubMed] [Google Scholar]
- Fang G., Burger H., Grimson R., Tropper P., Nachman S., Mayers D., Weislow O., Moore R., Reyelt C., Hutcheon N. Maternal plasma human immunodeficiency virus type 1 RNA level: a determinant and projected threshold for mother-to-child transmission. Proc Natl Acad Sci U S A. 1995 Dec 19;92(26):12100–12104. doi: 10.1073/pnas.92.26.12100. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Folks T. M., Powell D., Lightfoote M., Koenig S., Fauci A. S., Benn S., Rabson A., Daugherty D., Gendelman H. E., Hoggan M. D. Biological and biochemical characterization of a cloned Leu-3- cell surviving infection with the acquired immune deficiency syndrome retrovirus. J Exp Med. 1986 Jul 1;164(1):280–290. doi: 10.1084/jem.164.1.280. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Jackson J. B., Drew J., Lin H. J., Otto P., Bremer J. W., Hollinger F. B., Wolinsky S. M. Establishment of a quality assurance program for human immunodeficiency virus type 1 DNA polymerase chain reaction assays by the AIDS Clinical Trials Group. ACTG PCR Working Group, and the ACTG PCR Virology Laboratories. J Clin Microbiol. 1993 Dec;31(12):3123–3128. doi: 10.1128/jcm.31.12.3123-3128.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Kabengera S., Hom D., Jackson B. Effect of specimen storage on absolute CD4 counts. Clin Diagn Lab Immunol. 1994 Mar;1(2):232–234. doi: 10.1128/cdli.1.2.232-234.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Landay A., Ho J. L., Hom D., Russell T., Zwerner R., Minuty J. G., Kataaha P., Mmiro F., Jackson B. A rapid manual method for CD4+ T-cell quantitation for use in developing countries. AIDS. 1993 Dec;7(12):1565–1568. doi: 10.1097/00002030-199312000-00004. [DOI] [PubMed] [Google Scholar]
- Lin H. J., Myers L. E., Yen-Lieberman B., Hollinger F. B., Henrard D., Hooper C. J., Kokka R., Kwok S., Rasheed S., Vahey M. Multicenter evaluation of quantification methods for plasma human immunodeficiency virus type 1 RNA. J Infect Dis. 1994 Sep;170(3):553–562. doi: 10.1093/infdis/170.3.553. [DOI] [PubMed] [Google Scholar]
- Mellors J. W., Kingsley L. A., Rinaldo C. R., Jr, Todd J. A., Hoo B. S., Kokka R. P., Gupta P. Quantitation of HIV-1 RNA in plasma predicts outcome after seroconversion. Ann Intern Med. 1995 Apr 15;122(8):573–579. doi: 10.7326/0003-4819-122-8-199504150-00003. [DOI] [PubMed] [Google Scholar]
- Mulder J., McKinney N., Christopherson C., Sninsky J., Greenfield L., Kwok S. Rapid and simple PCR assay for quantitation of human immunodeficiency virus type 1 RNA in plasma: application to acute retroviral infection. J Clin Microbiol. 1994 Feb;32(2):292–300. doi: 10.1128/jcm.32.2.292-300.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
- O'Brien W. A., Hartigan P. M., Martin D., Esinhart J., Hill A., Benoit S., Rubin M., Simberkoff M. S., Hamilton J. D. Changes in plasma HIV-1 RNA and CD4+ lymphocyte counts and the risk of progression to AIDS. Veterans Affairs Cooperative Study Group on AIDS. N Engl J Med. 1996 Feb 15;334(7):426–431. doi: 10.1056/NEJM199602153340703. [DOI] [PubMed] [Google Scholar]
- Pachl C., Todd J. A., Kern D. G., Sheridan P. J., Fong S. J., Stempien M., Hoo B., Besemer D., Yeghiazarian T., Irvine B. Rapid and precise quantification of HIV-1 RNA in plasma using a branched DNA signal amplification assay. J Acquir Immune Defic Syndr Hum Retrovirol. 1995 Apr 15;8(5):446–454. doi: 10.1097/00042560-199504120-00003. [DOI] [PubMed] [Google Scholar]
- Welles S. L., Jackson J. B., Yen-Lieberman B., Demeter L., Japour A. J., Smeaton L. M., Johnson V. A., Kuritzkes D. R., D'Aquila R. T., Reichelderfer P. A. Prognostic value of plasma human immunodeficiency virus type 1 (HIV-1) RNA levels in patients with advanced HIV-1 disease and with little or no prior zidovudine therapy. AIDS Clinical Trials Group Protocol 116A/116B/117 Team. J Infect Dis. 1996 Oct;174(4):696–703. doi: 10.1093/infdis/174.4.696. [DOI] [PubMed] [Google Scholar]
- van Gemen B., Kievits T., Nara P., Huisman H. G., Jurriaans S., Goudsmit J., Lens P. Qualitative and quantitative detection of HIV-1 RNA by nucleic acid sequence-based amplification. AIDS. 1993 Nov;7 (Suppl 2):S107–S110. doi: 10.1097/00002030-199311002-00020. [DOI] [PubMed] [Google Scholar]